Choong Ang Vaccine Laboratory Co. Ltd (072020) - Total Liabilities

Latest as of March 2026: ₩17.61 Billion KRW ≈ $11.93 Million USD

Based on the latest financial reports, Choong Ang Vaccine Laboratory Co. Ltd (072020) has total liabilities worth ₩17.61 Billion KRW (≈ $11.93 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Choong Ang Vaccine Laboratory Co. Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Choong Ang Vaccine Laboratory Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Choong Ang Vaccine Laboratory Co. Ltd to evaluate short-term liquidity relative to the company's equity base.

Choong Ang Vaccine Laboratory Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Choong Ang Vaccine Laboratory Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Kredyt Inkaso SA
WAR:KRI
Poland zł564.43 Million
Evertex Fabrinology Ltd
TW:1470
Taiwan NT$196.08 Million
Raonsecure Co. Ltd
KQ:042510
Korea ₩20.77 Billion
Byuksan Corp
KO:007210
Korea ₩285.54 Billion
Ama Marine Public Company Limited
BK:AMA
Thailand ฿1.24 Billion
China Tianrui Group Cement Company Limited
F:T18
Germany €20.27 Billion
Glomac Bhd
KLSE:5020
Malaysia RM595.74 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Choong Ang Vaccine Laboratory Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Choong Ang Vaccine Laboratory Co. Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.38 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.16 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Choong Ang Vaccine Laboratory Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)

The table below shows the annual total liabilities of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 ₩17.45 Billion
≈ $11.82 Million
-10.11%
2024-12-31 ₩19.41 Billion
≈ $13.15 Million
-1.92%
2023-12-31 ₩19.79 Billion
≈ $13.41 Million
+1.20%
2022-12-31 ₩19.55 Billion
≈ $13.25 Million
-2.11%
2021-12-31 ₩19.98 Billion
≈ $13.54 Million
+14.61%
2020-12-31 ₩17.43 Billion
≈ $11.81 Million
+70.87%
2019-12-31 ₩10.20 Billion
≈ $6.91 Million
-13.11%
2018-12-31 ₩11.74 Billion
≈ $7.96 Million
-30.73%
2017-12-31 ₩16.95 Billion
≈ $11.49 Million
+28.61%
2016-12-31 ₩13.18 Billion
≈ $8.93 Million
+82.46%
2015-12-31 ₩7.22 Billion
≈ $4.89 Million
-16.11%
2014-12-31 ₩8.61 Billion
≈ $5.83 Million
--

About Choong Ang Vaccine Laboratory Co. Ltd

KQ:072020 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$61.71 Million
₩91.06 Billion KRW
Market Cap Rank
#21129 Global
#1201 in Korea
Share Price
₩9730.00
Change (1 day)
+0.62%
52-Week Range
₩8780.00 - ₩10140.00
All Time High
₩30815.73
About

Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Ko… Read more